Silexion TherapeuticsSLXN
13F holders, Q2 2025 (June 30)2holders
$0.81avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Silexion Therapeutics Corp. (SLXN) in their 13F filings. The largest holders were Moloney Securities Asset Management, LLC ($16K) and SBI Securities Co., Ltd. ($13K).
- Company
- Silexion Therapeutics Corp.
- CUSIP
- G1281K130
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $29K |
| Exits | 0 | $0 |
Ownership 2 holders
| Moloney Securities Asset Management, LLC | 0.00% | New | 20,000 | $16K |
| SBI Securities Co., Ltd. | 0.00% | New | 16,414 | $13K |
"% of holder's portfolio" is SLXN's weight in each manager's 13F, not the share of Silexion Therapeutics Corp. the manager owns.